{"id":46917,"date":"2017-10-11T09:47:29","date_gmt":"2017-10-11T09:47:29","guid":{"rendered":"https:\/\/www.biphoo.com\/bipnews\/?p=46917"},"modified":"2017-10-11T09:47:29","modified_gmt":"2017-10-11T09:47:29","slug":"medical-school-researchers-awarded-more-than-2-million-to-test-zika-vaccine-in-brazil","status":"publish","type":"post","link":"https:\/\/www.biphoo.com\/bipnews\/health\/medical-school-researchers-awarded-more-than-2-million-to-test-zika-vaccine-in-brazil.html","title":{"rendered":"Medical school researchers awarded more than $2 million to test Zika vaccine in Brazil"},"content":{"rendered":"<h2 style=\"text-align: justify\"><span style=\"font-size: 18pt\"><strong><span style=\"font-family: Arial, Helvetica, sans-serif;color: #000000\">Medical school researchers awarded more than $2 million to test Zika vaccine in Brazil<\/span><\/strong><\/span><\/h2>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">Researchers from the School of Medicine and Health Sciences have been awarded more than $2 million from a research contractor to run a Zika vaccine trial in Brazil, according to a release Monday.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">A team of researchers, including David Diemert and Jeffrey Bethony, associate professors in the department of microbiology, immunology and tropical medicine, will run a trial with 100 subjects in the city of Belo Horizonte, Brazil. About 2,400 people in total from across Central and South America, Puerto Rico and the southern United States will participate in the trial, according to the release.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">Leidos Biomedical Research, a Maryland-based contractor, will provide the grant to run the testing site in Brazil, according to the release.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">The researchers will monitor the transmission of the virus and study the safety of the vaccine, developed by the National Institutes of Health, compared to a placebo, according to the release.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">The Zika virus is a mosquito-borne illness that occurs seasonally in Brazil and is known to cause birth defects, according to the release. A high-profile Zika epidemic swept through South and Central America last year and eventually led to several cases in the United States.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">The DNA vaccine uses the virus\u2019 genetics to prepare a strong bodily response. It can be given to pregnant women, unlike a live virus, which can impact babies, according to the release.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">\u201cWe are going into what is expected to be the transmission season in Brazil,\u201d Diemert said in the release. \u201cThat\u2019s one of the reasons we are heading into this trial now. The people in these areas will be vaccinated before we would start to see cases of Zika.\u201d<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">The study will follow participants who receive the vaccine for a two-year period. If the study is successful, the vaccine could advance prevention techniques against Zika in affected areas, according to the release.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-size: 14pt;font-family: Arial, Helvetica, sans-serif;color: #000000\">The trial in Brazil will be completed in partnership with Hospital das Cl\u00ednicas and the Funda\u00e7\u00e3o Oswaldo Cruz in Belo Horizonte and is sponsored by the NIH\u2019s National Institute of Allergy and Infectious Disease, according to the release.<\/span><\/p>\n<p><span style=\"font-size: 8pt\">Source:-\u00a0https:\/\/www.gwhatchet.com\/2017\/10\/10\/medical-school-researchers-awarded-more-than-2-million-to-test-zika-vaccine-in-brazil\/<\/span><\/p>\n<div class=\"fb-background-color\">\n\t\t\t  <div \n\t\t\t  \tclass = \"fb-comments\" \n\t\t\t  \tdata-href = \"https:\/\/www.biphoo.com\/bipnews\/health\/medical-school-researchers-awarded-more-than-2-million-to-test-zika-vaccine-in-brazil.html\"\n\t\t\t  \tdata-numposts = \"10\"\n\t\t\t  \tdata-lazy = \"true\"\n\t\t\t\tdata-colorscheme = \"light\"\n\t\t\t\tdata-order-by = \"social\"\n\t\t\t\tdata-mobile=true>\n\t\t\t  <\/div><\/div>\n\t\t  <style>\n\t\t    .fb-background-color {\n\t\t\t\tbackground: #ffffff !important;\n\t\t\t}\n\t\t\t.fb_iframe_widget_fluid_desktop iframe {\n\t\t\t    width: 630px !important;\n\t\t\t}\n\t\t  <\/style>\n\t\t  ","protected":false},"excerpt":{"rendered":"<p>Medical school researchers awarded more than $2 million to test Zika vaccine in Brazil Researchers from the School of Medicine and Health Sciences have been awarded more than $2 million from a research contractor to run a Zika vaccine trial in Brazil, according to a release Monday. A team of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":46921,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[75154],"class_list":["post-46917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-medical-school-researchers-awarded-more-than-2-million-to-test-zika-vaccine-in-brazil"],"_links":{"self":[{"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/posts\/46917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/comments?post=46917"}],"version-history":[{"count":0,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/posts\/46917\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/media\/46921"}],"wp:attachment":[{"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/media?parent=46917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/categories?post=46917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.biphoo.com\/bipnews\/wp-json\/wp\/v2\/tags?post=46917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}